Grifols SA ADR (NASDAQ: GRFS) has a price-to-earnings ratio of 30.38x that is above its average ratio. Additionally, the 36-month beta value for GRFS is 0.38. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for GRFS is 258.07M and currently, short sellers hold a 1.48% ratio of that float. The average trading volume of GRFS on March 12, 2025 was 972.21K shares.
GRFS) stock’s latest price update
Grifols SA ADR (NASDAQ: GRFS)’s stock price has dropped by -1.42 in relation to previous closing price of 7.73. Nevertheless, the company has seen a loss of -12.51% in its stock price over the last five trading days. seekingalpha.com reported 2025-02-27 that Grifols remains a strong long-term investment due to its leading position in the plasma industry and improving financial fundamentals, despite short-term volatility and lack of a dividend. The company’s revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential for future profitability. Grifols’ valuation is attractive, with a potential upside to €20/share, driven by EPS growth and market expansion in plasma-derived products.
GRFS’s Market Performance
Grifols SA ADR (GRFS) has experienced a -12.51% fall in stock performance for the past week, with a 9.17% rise in the past month, and a 4.38% rise in the past quarter. The volatility ratio for the week is 4.61%, and the volatility levels for the past 30 days are at 4.53% for GRFS. The simple moving average for the past 20 days is -2.71% for GRFS’s stock, with a -3.81% simple moving average for the past 200 days.
GRFS Trading at 1.64% from the 50-Day Moving Average
After a stumble in the market that brought GRFS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.49% of loss for the given period.
Volatility was left at 4.53%, however, over the last 30 days, the volatility rate increased by 4.61%, as shares surge +5.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.57% lower at present.
During the last 5 trading sessions, GRFS fell by -13.09%, which changed the moving average for the period of 200-days by +5.29% in comparison to the 20-day moving average, which settled at $7.83. In addition, Grifols SA ADR saw 2.42% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for GRFS
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.38 for the gross margin
The net margin for Grifols SA ADR stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 0.99, with 0.27 for asset returns.
Currently, EBITDA for the company is 1.18 billion with net debt to EBITDA at -0.44. When we switch over and look at the enterprise to sales, we see a ratio of 0.72. The receivables turnover for the company is 6.93for trailing twelve months and the total asset turnover is 0.34. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.66.
Conclusion
In conclusion, Grifols SA ADR (GRFS) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
